Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5000
+0.0175 (3.63%)
At close: Aug 13, 2025, 4:00 PM
0.4650
-0.0350 (-7.00%)
Pre-market: Aug 14, 2025, 9:01 AM EDT
Harvard Bioscience Employees
As of December 31, 2024, Harvard Bioscience had 355 total employees, including 330 full-time and 25 part-time employees. The number of employees decreased by 61 or -14.66% compared to the previous year.
Employees
355
Change (1Y)
-61
Growth (1Y)
-14.66%
Revenue / Employee
$250,000
Profits / Employee
-$161,707
Market Cap
22.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HBIO News
- 2 days ago - Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 9 days ago - Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewsWire
- 4 weeks ago - Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewsWire
- 2 months ago - Harvard Bioscience Appoints John Duke to Board of Directors - GlobeNewsWire
- 3 months ago - Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET - GlobeNewsWire